Vanguard Fiduciary Trust »

Aim Immunotech shares owned by Vanguard Fiduciary Trust

Quarter-by-quarter ownership of Aim Immunotech (AIM) shares owned by Vanguard Fiduciary Trust from 13F filings

Historical chart of Vanguard Fiduciary Trust investment in Aim Immunotech

Tip: Access up to 7 years of quarterly data

All positions including Aim Immunotech held by Vanguard Fiduciary Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aim Immunotech by Vanguard Fiduciary Trust

Quarter filed Position value Share count Share price at filing
2026-03-31 $10k 18k 0.59

More positions owned by Vanguard Fiduciary Trust

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for Vanguard Fiduciary Trust

Top funds holding Aim Immunotech

Geode Capital Management
Hrt Financial
Jane Street
Vanguard Fiduciary Trust
Vanguard Group
Goss Wealth Management
Morgan Stanley
Community Bank
Tower Research Capital
Harbour Investments
Creative Financial Designs
Advisor Group Holdings
Hoey Investments
Steward Partners Investment Advisory
Farther Finance Advisors

View all funds holding Aim Immunotech